Harold E. Selick is Director at PDL BIOPHARMA, INC. (PDLI). They have made 9 open-market trades across 3 companies since 2007, most recently 2026-03-26.
CIK 0001287233
8 open-market purchases totalling $458K since 2007, against 1 sale. Across 8 scored buys the stock is up 14.7% at ninety days, and 11.8 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| PTGX | 60,845 | $8.7M |
| THLD | 433,870 | $2.6M |
| PDLI | 256,828 | $634K |
| CBIO | 16,232 | $225K |
| Total | $12.2M |
Shares reported on the most recent Form 4, priced at the 2026-03-27 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 13% | 13% |
| Avg Move | -21.4% | -2.5% | +14.7% |
| Alpha | -15.3% | -3.4% | +11.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PTGX | SELL | 2026-03-26 | 2026-03-27 | $105.00 | $2.5M | +5.1% | -0.5% | +23.8% |
| PTGX | BUY | 2020-03-12 | 2020-03-12 | $6.70 | $80K | -7.3% | +4.2% | +141.8% |
| PDLI | BUY | 2014-11-26 | 2014-11-28 | $8.08 | $48K | -11.2% | -0.3% | -0.3% |
| THLD | BUY | 2011-03-11 | 2011-03-15 | $2.10 | $100K | -25.5% | -4.0% | -4.0% |
| THLD | BUY | 2009-10-05 | 2009-10-06 | $1.86 | $97K | -25.5% | -4.0% | -4.0% |
| THLD | BUY | 2009-06-03 | 2009-06-05 | $1.52 | $30K | -25.5% | -4.0% | -4.0% |
| THLD | BUY | 2008-08-29 | 2008-09-05 | $2.04 | $100K | -25.5% | -4.0% | -4.0% |
| THLD | BUY | 2007-11-29 | 2007-12-03 | $0.56 | $2K | -25.5% | -4.0% | -4.0% |
| THLD | BUY | 2007-11-21 | 2007-11-26 | $0.56 | $168 | -25.5% | -4.0% | -4.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.